<PAGE>
-------------------------------
/ OMB APPROVAL /
-------------------------------
/ OMB Number: 3235-0145/
/ Expires: December 31, 1997/
/ Estimated average burden /
/ hours per response.... 14.90/
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6)*
Baker Hughes Incorporated
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
057224107
- --------------------------------------------------------------------------------
(CUSIP Number)
Scott Renwick One East Wacker Drive
(312) 661-4520 Chicago, Illinois 60601
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
October 27, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of (S)(S)240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [_].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See (S)240.13d-7(b) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4
<PAGE>
SCHEDULE 13D
----------------------- ---------------------
CUSIP NO. 057224107 PAGE 2 OF 4 PAGES
----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Unitrin, Inc.
95-4255452
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
2 (a) _____
(b) _____
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS (See Instructions)
4
See Item 3.
- ------------------------------------------------------------------------------
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
5
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 576,049
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
15,816,912
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
576,049
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
15,816,912
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
16,392,961
- ------------------------------------------------------------------------------
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12 (See Instructions)
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
4.98%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (See Instructions)
14
HC, CO
- ------------------------------------------------------------------------------
<PAGE>
CUSIP No. 057224107 Page 3 of 4 Pages
Amendment No. 6 to Schedule 13D
The information reported previously in Unitrin's Schedule 13D, dated August
10, 1998, as amended by Amendment No. 1 thereto, dated October 19, 1998,
Amendment No. 2 thereto, dated March 22, 1999, Amendment No. 3 thereto, dated
March 29, 1999, Amendment No. 4 thereto, dated April 16, 1999 and Amendment No.
5 thereto, dated September 9, 1999 (the "Previous 13D") is supplemented with the
following information. Capitalized terms used below and not otherwise defined
have the meanings given to such terms in the Previous 13D.
Item 4. Purpose of Transaction
The filing persons have no plans or proposals which relate to items 4(b)
through 4(j) of Schedule 13D. The filing persons presently intend to sell an
indeterminate number of shares of Baker Hughes common stock in market
transactions, subject to market conditions and other factors. Future investment
considerations by the filing persons might or might not result in the
acquisition of additional securities of Baker Hughes.
Item 5. Interest in Securities of the Issuer
Unitrin reported in the Previous 13D that it had sole voting and
dispositive power with respect to 3,394,049 shares of Baker Hughes common stock
and shared voting and dispositive power with respect to 15,816,912 shares of
Baker Hughes held by two wholly-owned subsidiaries of Unitrin, resulting in
total beneficial ownership, direct and indirect, of 19,210,961 shares.
During the period beginning on September 10, 1999 and ending on October 27,
1999, Unitrin conducted a series of open market sales of Baker Hughes common
stock in unsolicited brokerage transactions and otherwise in accordance with
Rule 144 of the Securities and Exchange Commission. The average sale price for
these transactions was approximately $30.22 per share. As a result of these
transactions, Unitrin now has sole voting and dispositive power with respect to
576,049 shares of Baker Hughes common stock and shared voting and dispositive
power with respect to 15,816,912 of such shares held by two wholly-owned
subsidiaries of Unitrin. Accordingly, Unitrin's total beneficial ownership,
direct and indirect, of Baker Hughes common stock is 16,392,961 shares as of
October 27, 1999.
As a result of the transactions reported in this Amendment No. 6, Unitrin
and its subsidiaries collectively own less than 5% of Baker Hughes common stock
and, accordingly, are no longer individually or collectively subject to Schedule
13D filing requirements.
<PAGE>
CUSIP No. 057224107 Page 4 of 4 Pages
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATE: October 27, 1999 UNITRIN, INC.
By: /s/ Scott Renwick
-------------------------------
Scott Renwick
Secretary
